Phase 2 N=55 Randomized Single-blind Treatment

Transdermal Electroacupuncture for Opioid Detoxification

Opioid Dependency

Bottom Line

View on ClinicalTrials.gov: NCT00742170 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2014

Primary outcome: Primary: Percent of Participants Using Drugs — 35; 77 percent

Study Design & Population

Study type: Interventional
Phase: Phase 2
Interventions: Electroacupuncture (Device)
Age: Adult · 18+ yrs
Sex: All
Sponsor: Mclean Hospital
Primary completion: Oct 2009

Outcome Measures

Outcome	Result	p-value
PRIMARY Percent of Participants Using Drugs	35; 77	—
SECONDARY Opioid Craving (Self-report)	10.7; 14.3	—

Summary

This single-blind, randomized clinical trial tests whether electroacupuncture, provided as an adjunctive treatment, improves outcomes among patients receiving inpatient opioid detoxification from opioids.

Eligibility Criteria

Inclusion Criteria

Current opioid dependence
Current buprenorphine detoxification
18-59 years of age
English proficiency

Exclusion Criteria

Acute mania, psychosis, or suicidality
Cognitive impairments precluding informed consent
Heart disease or contraindicated heart condition
Use of pace maker
History of seizure disorder
Current detoxification from alcohol or benzodiazepines
Inability to return to follow-up visits
For women, pregnancy

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00742170). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.